Tvastra Innotech Solutions | WELCOME – Research – Product

DIscover THE Growth secretes

Unravel business growth through Pharma Research, BioMedical Research & manufacturing & Engineering Consulting (Oil and gas) services.

We are

We are a multi-disciplinary research & development company that is committed to synthesis process (patent potential) of manufacturing the API (Active Pharmaceutical Ingredient) & biomedical products. We also provide high quality compliant API sourcing services to pharma product manufacturers across globe.

Pharma Sector

We are developing a new synthesis process with patent potential for an existing active pharmaceutical ingredient (API). We also undertake sourcing & commercial scale manufacturing & Validations

Research & Development

We are developing a new synthesis process with patent potential for an existing active pharmaceutical ingredient (API) which is currently manufactured by only one company.

Process Development and optimization

We develop processes to achieve the final product without unwanted impurities with a potential process patent. We also providing service to source APIs to our clients.

Contract Sourcing & manufacturing APIs

We provide service to source APIs to our clients. Our services are delivered where a quality compliant product is sourced to the client at competitive price in a timely manner.

Validation

We are developing unique and cost-effective process solutions to API manufacturing of few pharma products by using chemistry & process engineering.

Biomedical Research & Manufacturing

We collaborate across all stakeholders inside company as well as across Pharma ecosystem, with a focus on innovations to produce patent potential generics. Our research focused on infectious tropical diseases, epigenetics, growth control and neurobiology.

NanoVesicles (Stem cell membrane-based)

Stem cell membrane-based nanovesicles have innate tumor targeting abilities and are simple to prepare compared to the very cumbersome preparation of surface functionalized synthetic nanoparticles and their associated limitations. Since the nanovesicles are from a natural source and immune privileged, there is very little immune rejection upon the administration into the patient.

Donor cornea (NanoParticle-Engineered)

Sustained delivery of drugs which can maintain barrier function of the donor corneal endothelium, and thus can overcome hypothermia and cytokine stress. Currently, no such treatment exist, and hence our solution is unique.

Oxygen NanoSensors (Contact lens-based)

Non-invasive, patient friendly, rapid measurement and in situ measurement of oxygen dynamics in the tear film, which has the potential to diagnose various hypoxia-induced ocular disorders.